Inventor · disambiguated record
Dominik Ruettinger
Also filed as: RUETTINGER DOMINIK
3 granted patents·8 pending applications·24 citations·filing 2013–2025
63Inventor score
Files withHOFFMANN LA ROCHE11
Top patents by PatentIndex Score
11 records- 0192US9192667B2Method of treating cancer by administering CSF-1R antibodies and a TLR9 agonistHOFFMANN LA ROCHE·Filed 2014·Granted Nov 24, 2015·22 cites·13 claims
- 0269US11498968B2Treatment of tumors with an anti-CSF-1R antibody in combination with an anti-PD-L1 antibody after failure of anti-PD-L1/PD1 treatmentHOFFMANN LA ROCHE·Filed 2019·Granted Nov 15, 2022·2 cites·12 claims
- 0365US2025266130A1Cancer PrognosisHOFFMANN LA ROCHE·Filed 2025·Application pending·0 cites
- 0461US2019185572A1Combination therapy of antibodies against human csf-1r and uses thereofHOFFMANN LA ROCHE·Filed 2018·Application pending·0 cites
- 0555US2017247459A1Combination therapy of antibodies against human csf-1r and uses thereofHOFFMANN LA ROCHE·Filed 2016·Application pending·0 cites
- 0653US2022165362A1Cancer prognosisHOFFMANN LA ROCHE·Filed 2020·Application pending·0 cites
- 0752US2014079706A1Combination therapy of antibodies against human csf-1r and uses thereofHOFFMANN LA ROCHE·Filed 2013·Application pending·0 cites
- 0852US2024094212A1Novel biomarkers and uses thereofHOFFMANN LA ROCHE·Filed 2023·Application pending·0 cites
- 0949US2016220669A1Combination therapy of antibodies against human csf-1r and tlr9 agonistHOFFMANN LA ROCHE·Filed 2015·Application pending·0 cites
- 1048US2023335285A1Method of determining a risk of mortality of a cancer patient, method of assessing an anti-cancer therapy, method of selecting cancer patients for treatmentHOFFMANN LA ROCHE·Filed 2021·Application pending·0 cites
- 1137US11542335B2Method of treating cancer in a patient by administering an antibody which binds colony stimulating factor-1 receptor (CSF-1R)HOFFMANN LA ROCHE·Filed 2019·Granted Jan 3, 2023·0 cites·12 claims
Join the waitlist — get patent alerts
Get an alert when Dominik Ruettinger files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →